Pathos AI teams up with Bristol Myers and Tempus AI to advance drug development

Economic Times TechOctober 23, 2026en

Pathos AI said on Friday it had entered into a collaboration with Bristol Myers Squibb and Tempus AI to develop artificial intelligence tools for drug development in Alzheimer's

This is a short summary published by AI Global Wire. The full article is owned and hosted by Economic Times Tech — open it there to read it in full.

• Verktyg